Brian J. Underdown

Venture Partner at Lumira Capital Investment Management, Inc.

Brian J. Underdown

Brian J. Underdown

Venture Partner at Lumira Capital Investment Management, Inc.

Overview
Career Highlights

DC Bio Corp.
MedInnova Partners, Inc.
MedTech Partners, Inc.

RelSci Relationships

772

Number of Boards

25

Birthday

1941

Age

80

Relationships
RelSci Relationships are individuals Brian J. Underdown likely has professional access to. A relationship does not necessarily indicate a personal connection.

Co-Founder at VistaGen Therapeutics, Inc.

Relationship likelihood: Strong

Managing Partner, Montreal at TVM Life Science Management, Inc.

Relationship likelihood: Strong

Chief Operating Officer & General Counsel at Cato Holding Co.

Relationship likelihood: Strong

Chief Executive Officer at STEM CELL THERAPEUTICS CORP

Relationship likelihood: Strong

President & Chief Executive Officer at Amgen Boulder, Inc.

Relationship likelihood: Strong

Managing Partner & Founder at Proteus RM LLC (Venture Capital)

Relationship likelihood: Strong

Chairman, President & Chief Executive Officer at OsteoqQC, Inc.

Relationship likelihood: Strong

Chief Executive Officer & Director at Novadip Biosciences SA

Relationship likelihood: Strong

Venture Partner at Lumira Capital Investment Management, Inc.

Relationship likelihood: Strong

Venture Partner at Lumira Capital Investment Management, Inc.

Relationship likelihood: Strong

Paths to Brian J. Underdown
Potential Connections via
Relationship Science
You
Brian J. Underdown
Venture Partner at Lumira Capital Investment Management, Inc.
Education
Ph.D Immunology

McGill University is a public research university located in Montreal, Quebec, Canada. Founded in 1821 during the British colonial era, the university bears the name of James McGill, a prominent Montreal merchant from Glasgow, Scotland and alumnus of Glasgow University, whose bequest formed the beginning of the university.

Post Doctorate

A leader in medical research, teaching and patient care, Washington University School of Medicine is currently ranked fourth in the nation by U.S. News & World Report. The School's 2,100 employed and volunteer faculty physicians and clinicians -- known as Washington University Physicians -- are also medical staff members of Barnes-Jewish and St. Louis Children's hospitals. The clinical practice group provides care to more than 430,000 children and adults at 49 clinical sites annually. Together, the institutions located on the Washington University Medical Center campus employ more than 21,000 clinicians, scientists, residents, fellows, administrators and support staff.

Career History
Venture Partner
1997 - Current

LUMIRA primarily focuses on later stage biopharmaceutical and medical device companies located in US and Canada. The firm partners with management teams and also invests in health IT and consumer health sectors.

Chief Executive Officer
Current

MedInnova Partners provides financing for seed and early-stage capital requirements. The firm focuses on pharma and health care businesses located in Canada.

President
Current

DC Bio Corp. develops technology for application to cancer and diseases associated with chronic viral infections. The company is headquartered in Halifax, Canada.

Boards & Committees
Chairman
Current

Ontario Genomics Institute focuses on using world-class research to create strategic genomics resources and to accelerate Ontario's development of a globally-competitive life sciences sector. They strategically cultivate, fund and manage large-scale genomics projects and the genomics resources they create, as well as technology development and technology service platform provision associated with these projects.OGI aims to provide early-stage funding as companies (on their own or with academic collaborators) move towards commercial applications and to speed up transfer of products from lab to marketplace. The fund invests up to $100K per project. They tend to invest in the following sectors: Biofuels, Diagnostics, therapeutics, Crop or livestock trait improvements, Environmental management (related to water, mining, energy, other), Forestry, Laboratory and medical devices, Food, Informatics including databases, software, other tools.

Director
Prior - 2011

VistaGen Therapeutics, Inc. is a South San Francisco-based biotechnology company that focuses on providing clinically relevant, commercially scalable, human stem cell biology-based screening systems capable of predicting the safety and efficacy of new drugs in ways never before possible. VistaGen's Clinical Trials in a Test Tube platform is designed to generate predictive information that results in reduced probability of clinical trial drug failures, especially failures associated with heart and liver toxicity. VistaGen expects its new-generation stem cell-based human systems biology platform to enhance dramatically the pharmaceutical industry's ability to deliver innovative drugs for some of the world's most challenging diseases and conditions.

Director
Prior - 2011

Excaliber Enterprises Ltd. is a development stage company. It is engaged in the business of selling specialty gift baskets to health care professionals, organizations and patients, and real estate agents and firms. The company was founded on October 6, 2005 and is headquartered in Rathdrum, ID.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Brian J. Underdown. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Brian J. Underdown's profile does not indicate a business or promotional relationship of any kind between RelSci and Brian J. Underdown.